Veronica Vernier
YOU?
Author Swipe
View article: P14.21.B ROLE OF 11C-METHIONINE POSITRON EMISSION TOMOGRAPHY EMPLOY BEYOND THAT ADVANCED MAGNETIC RESONANCE IMAGING FOR TARGET VOLUME DELINEATION IN PATIENTS UNDERWENT RE-IRRADIATION FOR RECURRENT GLIOBLASTOMA
P14.21.B ROLE OF 11C-METHIONINE POSITRON EMISSION TOMOGRAPHY EMPLOY BEYOND THAT ADVANCED MAGNETIC RESONANCE IMAGING FOR TARGET VOLUME DELINEATION IN PATIENTS UNDERWENT RE-IRRADIATION FOR RECURRENT GLIOBLASTOMA Open
BACKGROUND Reirradiation for recurrent glioblastoma patients is a challenging and important topic under investigation. No clear evidences exists regarding indications, sequences with other therapeutic approach, optimal dose to delivered, a…
View article: P17.12.B LEPTOMENINGEAL DISEASE FOLLOWING POSTOPERATIVE RADIOSURGERY IN RESECTED BRAIN METASTASES: LONG TERM FOLLOW UP OF A PHASE 2 STUDY
P17.12.B LEPTOMENINGEAL DISEASE FOLLOWING POSTOPERATIVE RADIOSURGERY IN RESECTED BRAIN METASTASES: LONG TERM FOLLOW UP OF A PHASE 2 STUDY Open
BACKGROUND Brain metastases (BMs) affect about 20-40% of patients with solid primary tumors, and as many as 25% of patients will harbor large BMs. Surgical resection followed by postoperative stereotactic radiosurgery has become the standa…
View article: Predictive Factors for Long-Term Disease Control in Systemic Treatment-Naïve Oligorecurrent Renal Cell Carcinoma Treated with Up-Front Stereotactic Ablative Radiotherapy (SABR)
Predictive Factors for Long-Term Disease Control in Systemic Treatment-Naïve Oligorecurrent Renal Cell Carcinoma Treated with Up-Front Stereotactic Ablative Radiotherapy (SABR) Open
Background: Stereotactic ablative radiotherapy (SABR) is emerging as a potential local treatment option for oligometastatic RCC. This study aims to evaluate the efficacy of SABR in patients with oligorecurrent RCC. Methods: A total of 50 p…
View article: Long term update on toxicity and survival of a phase II trial of linac‐based stereotactic body radiation therapy for low‐intermediate risk prostate cancer
Long term update on toxicity and survival of a phase II trial of linac‐based stereotactic body radiation therapy for low‐intermediate risk prostate cancer Open
Background In 2016 we published a phase II study exploring safety and efficacy of Stereotactic Body Radiation Therapy (SBRT) delivered with Volumetric Modulated Arc Therapy (VMAT) and Flattening Filter Free (FFF) beams techniques in prosta…
View article: Dataset related to article "Total tumor volume as a predictor of survival in patients with multiple oligometastases treated with stereotactic ablative radiotherapy (SABR)"
Dataset related to article "Total tumor volume as a predictor of survival in patients with multiple oligometastases treated with stereotactic ablative radiotherapy (SABR)" Open
This record contains raw data related to article "Total tumor volume as a predictor of survival in patients with multiple oligometastases treated with stereotactic ablative radiotherapy (SABR)"AbstractBackground: Delivering stereotactic ab…
View article: Dataset related to article "Predictive value of clinical and radiomic features for radiation therapy response in patients with lymph node-positive head and neck cancer"
Dataset related to article "Predictive value of clinical and radiomic features for radiation therapy response in patients with lymph node-positive head and neck cancer" Open
<p><strong> Abstract</strong></p><p>Background: Prediction of survival and radiation therapy response is challenging in head and neck cancer with metastatic lymph nodes (LNs). Here we developed novel radi…
View article: Dataset related to article "Stereotactic radiation therapy for oligometastatic esophagogastric adenocarcinoma: outcome and prognostic factors"
Dataset related to article "Stereotactic radiation therapy for oligometastatic esophagogastric adenocarcinoma: outcome and prognostic factors" Open
<p>This record contains raw data related to article "Stereotactic radiation therapy for oligometastatic esophagogastric adenocarcinoma: outcome and prognostic factors"</p><p>Abstract</p><p><strong>Object…
View article: Dataset related to article "The pattern of failure after Stereotactic Radiation Therapy (SRT) for oligo-metastases: predictive factors for poly-progression "
Dataset related to article "The pattern of failure after Stereotactic Radiation Therapy (SRT) for oligo-metastases: predictive factors for poly-progression " Open
This record contains raw data related to article "The pattern of failure after Stereotactic Radiation Therapy (SRT) for oligo-metastases: predictive factors for poly-progression"AbstractPurpose: Patients with oligo-metastatic disease (OMD)…
View article: Dataset related to article "Stereotactic Body Radiation Therapy for Lung and Liver Oligometastases from Breast Cancer: Toxicity Data of a Prospective Non-Randomized Phase II Trial"
Dataset related to article "Stereotactic Body Radiation Therapy for Lung and Liver Oligometastases from Breast Cancer: Toxicity Data of a Prospective Non-Randomized Phase II Trial" Open
<p>This record contains raw data related to article "Stereotactic Body Radiation Therapy for Lung and Liver Oligometastases from Breast Cancer: Toxicity Data of a Prospective Non-Randomized Phase II Trial"</p><p>Abstract&…
View article: Total tumor volume as a predictor of survival in patients with multiple oligometastases treated with stereotactic ablative radiotherapy (SABR)
Total tumor volume as a predictor of survival in patients with multiple oligometastases treated with stereotactic ablative radiotherapy (SABR) Open
Background: Delivering stereotactic ablative radiotherapy (SABR) in patients with multiple oligometastases represents a challenge for clinical and technical reasons. We aimed to evaluate the outcome of patients affected by multiple oligome…
View article: Dataset related to article "Internal Guidelines for Reducing Lymph Node Contour Variability in Total Marrow and Lymph Node Irradiation "
Dataset related to article "Internal Guidelines for Reducing Lymph Node Contour Variability in Total Marrow and Lymph Node Irradiation " Open
This record contains raw data related to article “Internal Guidelines for Reducing Lymph Node Contour Variability in Total Marrow and Lymph Node Irradiation" Background: The total marrow and lymph node irradiation (TMLI) target includes t…
View article: Dataset related to article "Internal Guidelines for Reducing Lymph Node Contour Variability in Total Marrow and Lymph Node Irradiation "
Dataset related to article "Internal Guidelines for Reducing Lymph Node Contour Variability in Total Marrow and Lymph Node Irradiation " Open
This record contains raw data related to article “Internal Guidelines for Reducing Lymph Node Contour Variability in Total Marrow and Lymph Node Irradiation" Background: The total marrow and lymph node irradiation (TMLI) target includes t…
View article: Internal Guidelines for Reducing Lymph Node Contour Variability in Total Marrow and Lymph Node Irradiation
Internal Guidelines for Reducing Lymph Node Contour Variability in Total Marrow and Lymph Node Irradiation Open
Background: The total marrow and lymph node irradiation (TMLI) target includes the bones, spleen, and lymph node chains, with the latter being the most challenging structures to contour. We evaluated the impact of introducing internal cont…
View article: Predictive value of clinical and radiomic features for radiation therapy response in patients with lymph node‐positive head and neck cancer
Predictive value of clinical and radiomic features for radiation therapy response in patients with lymph node‐positive head and neck cancer Open
Background Prediction of survival and radiation therapy response is challenging in head and neck cancer with metastatic lymph nodes (LNs). Here we developed novel radiomics‐ and clinical‐based predictive models. Methods Volumes of interest…
View article: Stereotactic radiation therapy for oligometastatic esophagogastric adenocarcinoma: outcome and prognostic factors
Stereotactic radiation therapy for oligometastatic esophagogastric adenocarcinoma: outcome and prognostic factors Open
Objective: The aim of this study was to evaluate clinical results and prognostic factors in a cohort of patient with oligometastatic esophagogastric adenocarcinoma treated with stereotactic radiation therapy (SRT). Methods: This retrospect…
View article: Stereotactic Body Radiation Therapy for Lung and Liver Oligometastases from Breast Cancer: Toxicity Data of a Prospective Non-Randomized Phase II Trial
Stereotactic Body Radiation Therapy for Lung and Liver Oligometastases from Breast Cancer: Toxicity Data of a Prospective Non-Randomized Phase II Trial Open
Aims: We report the mature toxicity data of a phase II non-randomized trial on the use of SBRT for lung and liver oligometastases. Methods: Oligometastatic patients from breast cancer were treated with SBRT for up to five lung and/or liver…
View article: The pattern of failure after Stereotactic Radiation Therapy (SRT) for oligometastases: predictive factors for poly progression
The pattern of failure after Stereotactic Radiation Therapy (SRT) for oligometastases: predictive factors for poly progression Open
Purpose Patients with oligometastatic disease (OMD) can be safely treated with Stereotactic Radiation Therapy (SRT). Further disease progression is common in these patients. In most cases, patients relapse again with oligometastases, howev…